Amylin Pharmaceuticals (AMLN) NewsBite - One of Today's Top Gainers On Takeda Deal

Amylin Pharmaceuticals (AMLN) leads the list of top gainers so far today and is now at $12.14, up $1.10 (9.96%) on volume of 12,236,203 shares traded. Over the last 52 weeks the stock has ranged from a low of $5.50 to a high of $15.69. The stock is seeing momentum today on news that it signed a deal with Japan's Takeda Pharmaceutical Co. on potential weight-loss treatments that could bring AMLN up to $1 billion. Amylin Pharmaceuticals stock has been showing support around $10.69 and resistance in the $11.67 range. Technical indicators for the stock are neutral and S&P gives AMLN a neutral 3 STARS (out of 5) hold ranking. If you are looking for a hedged play on AMLN the stock seems like it could be a candidate for a January out-of-the-money bull-put credit spread below the 10 range.

ABR-Seven Summits Strategic Investments NewsBite Goto www.iotogo.com/18w1 for our free report titled, The 18 Ways To Know When It's Time To Dump A Stock

Related terms: japan, pharmaceuticals, S&P